Patients who plan to receive the second cycle of HDAC consolidation chemotherapy. [clinicaltrials_resource:328ace97a8562bb4075aa7a45b164c15]

Patients who plan to receive the second cycle of HDAC consolidation chemotherapy. [clinicaltrials_resource:328ace97a8562bb4075aa7a45b164c15]

Inclusion Criteria [clinicaltrials_vocabulary:Inclusion-Criteria]
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
http://bio2rdf.org/clinicaltrials_resource:328ace97a8562bb4075aa7a45b164c15

Patients who plan to receive the second cycle of HDAC consolidation chemotherapy. [clinicaltrials_resource:328ace97a8562bb4075aa7a45b164c15]

Inclusion Criteria [clinicaltrials_vocabulary:Inclusion-Criteria]
clinicaltrials resource [clinicaltrials_vocabulary:Resource]
http://bio2rdf.org/clinicaltrials_resource:328ace97a8562bb4075aa7a45b164c15
Bio2RDF identifier
328ace97a8562bb4075aa7a45b164c15
Bio2RDF namespace
Bio2RDF uri
http://bio2rdf.org/clinicaltrials_resource:328ace97a8562bb4075aa7a45b164c15
identifier
clinicaltrials_resource:328ace97a8562bb4075aa7a45b164c15
title
Patients who plan to receive the second cycle of HDAC consolidation chemotherapy.
@en
inDataset
type
label
Patients who plan to receive t ...... ace97a8562bb4075aa7a45b164c15]
@en